Adjuvance
2009
FOUNDED
PRIVATE
STATUS
Series A1
LATEST DEAL TYPE
$20M
LATEST DEAL AMOUNT
4
INVESTORS
Description
Operator of a bio-pharmaceutical company designed to offer vaccines. The company's SAPONEX products are critical components that are added to many vaccines, enabling people to improve their immunity system.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Primary Office
- 1225 L Street
- Suite 600
- Lincoln, NE 68508
- United States
+1 (402) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Adjuvance’s full profile, request a free trial.
Adjuvance Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series A1) | 29-Jan-2020 | $20M | 000.00 | 0000 | Completed | Pre-Clinical Trials |
| 2. Seed Round | 29-Aug-2019 | 00.00 | 00.00 | Completed | Pre-Clinical Trials | |
| 1. Grant | 31-May-2015 | $1.5M | Completed | Startup |
Adjuvance Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A-2 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Adjuvance Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Morningside Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Invest Nebraska | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Mont Alto Capital | Family Office | Minority | 000 0000 | 000000 0 | ||
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 |
Adjuvance Executive Team (9)
2 Former Executives
You’re viewing 5 of 9 executives. Get the full list »Adjuvance Board Members (9)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Gregory Poland | Adjuvance | Vice Chairman & Advisor | 000 0000 | |
| Isaac Cheng MD | Self | Board Member | 000 0000 | |
| John Gallo | Adjuvance | Board Member | 000 0000 | |
| Ken Kelley | Adjuvance | Board Member | 000 0000 | |
| Mary Gin | Adjuvance | Board Member | 000 0000 |
2 Former Board Members
You’re viewing 5 of 9 board members. Get the full list »